Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.47 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24848726 | 0.88 | PDCD1 (0.44) | ALKBH5FTOALDH1A1L3MBTL1DUSP3 | |
| SCHEMBL17902070 | 0.87 | KDM4E (0.48) | ALKBH5FTOALDH1A1L3MBTL1LMNA | |
| SCHEMBL20988508 | 0.85 | ALKBH5 (0.43) | ALKBH5FTOALDH1A1L3MBTL1DUSP3 | |
| SCHEMBL17995394 | 0.83 | ALKBH5 (0.61) | ALKBH5FTOTSHRALDH1A1L3MBTL1 | |
| SCHEMBL18020159 | 0.83 | ALDH1A1 (0.40) | ALKBH5FTOTSHRALDH1A1L3MBTL1 | |
| SCHEMBL12447618 | 0.83 | POLB (0.44) | TSHRALDH1A1L3MBTL1DUSP3SMN1; SMN2 | |
| SCHEMBL24311511 | 0.82 | ALKBH5 (0.40) | ALKBH5FTOTSHRALDH1A1L3MBTL1 | |
| SCHEMBL25028761 | 0.82 | DUSP3 (0.43) | ALDH1A1L3MBTL1LMNADUSP3KDM4E | |
| SCHEMBL21742665 | 0.82 | KDM4E (0.49) | ALKBH5FTOL3MBTL1DUSP3RAB9A | |
| SCHEMBL26570042 | 0.82 | ALKBH5 (0.45) | ALKBH5FTOTSHRALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287011-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-09-14 | — | — | US | disclosed |
| US-20230049161-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-02-16 | — | — | US | disclosed |
| US-20230041530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-02-09 | — | — | US | disclosed |
| US-20230002417-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230287011-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OXGR1, OCIAD1 | ALKBH5 2293/4885FTO 435/4885TSHR 398/4885 |
| US-20230002417-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, ODC1 | ALKBH5 929/4885FTO 53/4885TSHR 4211/4885 |
| US-20230049161-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ICOSLG, AOC2, OCIAD1 | ALKBH5 1306/4885FTO 534/4885TSHR 2656/4885 |
| US-20230041530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, CHRM1 | ALKBH5 4434/4885FTO 1697/4885TSHR 355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.